Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [41] Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting
    Brandao, Angela Pires
    Watanabe Pinhata, Juliana Maira
    Simonsen, Vera
    Oliveira, Rosangela Siqueira
    Ghisi, Kelen Teixeira
    Silva Rabello, Michelle Christiane
    Fukasava, Suely
    Ferrazoli, Lucilaine
    TUBERCULOSIS, 2020, 125
  • [42] Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis
    Islam, Md Mahmudul
    Alam, Md Shah
    Liu, Zhiyong
    Khatun, Mst Sumaia
    Yusuf, Buhari
    Hameed, H. M. Adnan
    Tian, Xirong
    Chhotaray, Chiranjibi
    Basnet, Rajesh
    Abraha, Haftay
    Zhang, Xiaofan
    Khan, Shahzad Akbar
    Fang, Cuiting
    Li, Chunyu
    Hasan, Sohel
    Tan, Shouyong
    Zhong, Nanshan
    Hu, Jinxing
    Zhang, Tianyu
    FRONTIERS IN MEDICINE, 2024, 10
  • [43] Streptomycin Resistance and Lineage-Specific Polymorphisms in Mycobacterium tuberculosis gidB Gene
    Spies, Fernanda S.
    Ribeiro, Andrezza W.
    Ramos, Daniela F.
    Ribeiro, Marta O.
    Martin, Anandi
    Palomino, Juan Carlos
    Rossetti, Maria Lucia R.
    da Silva, Pedro Eduardo A.
    Zaha, Arnaldo
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (07) : 2625 - 2630
  • [44] Mycobacterium tuberculosis Gene Expression Associated With Fluoroquinolone Resistance and Efflux Pump Inhibition
    van der Heijden, Yuri F.
    Maruri, Fernanda
    Blackman, Amondrea
    Morrison, Robert
    Guo, Yan
    Sterling, Timothy R.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (04) : 469 - 478
  • [45] Spoligotype Defined Lineages of Mycobacterium tuberculosis and Drug Resistance: Merely a Casual Correlation?
    Panwalkar, Nikita
    Chauhan, Devendra S.
    Desikan, Prabha
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 35 (01) : 27 - 32
  • [46] Diagnostic Utility of GenoType MTBDRsl assay for the Detection of Moxifloxacin-Resistant Mycobacterium tuberculosis, as Compared to Phenotypic Method and Whole-Genome Sequencing
    Yadav, Raj Narayan
    Bhalla, Manpreet
    Kumar, Gavish
    Sah, Grish C.
    Dewan, Ravindra Kumar
    Singhal, Ritu
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2022, 11 (02) : 183 - 189
  • [47] Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
    Miotto, Paolo
    Cabibbe, Andrea M.
    Feuerriegel, Silke
    Casali, Nicola
    Drobniewski, Francis
    Rodionova, Yulia
    Bakonyte, Daiva
    Stakenas, Petras
    Pimkina, Edita
    Augustynowicz-Kopec, Ewa
    Degano, Massimo
    Ambrosi, Alessandro
    Hoffner, Sven
    Mansjo, Mikael
    Werngren, Jim
    Ruesch-Gerdes, Sabine
    Niemann, Stefan
    Cirillo, Daniela M.
    MBIO, 2014, 5 (05):
  • [48] Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis
    Gygli, Sebastian M.
    Keller, Peter M.
    Ballif, Marie
    Blochliger, Nicolas
    Homke, Rico
    Reinhard, Miriam
    Loiseau, Chloe
    Ritter, Claudia
    Sander, Peter
    Borrell, Sonia
    Collantes Loo, Jimena
    Avihingsanon, Anchalee
    Gnokoro, Joachim
    Yotebieng, Marcel
    Egger, Matthias
    Gagneux, Sebastien
    Bottger, Erik C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [49] Antimicrobial Resistance in Mycobacterium tuberculosis: The Odd One Out
    Eldholm, Vegard
    Balloux, Francois
    TRENDS IN MICROBIOLOGY, 2016, 24 (08) : 637 - 648
  • [50] Efflux pump effects on Mycobacterium tuberculosis drug resistance
    Valiyeva, Gumral
    Durupinar, Belma
    Coban, Ahmet Yilmaz
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (07) : 601 - 609